Elanco Animal Health INC Form 4 insider transactions

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units on November 1, 2024.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on November 1, 2024.

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reports the acquisition of deferred stock units convertible to common stock or cash.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units on October 4, 2024.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reports the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

Director Lawrence Kurzius reports acquisition of deferred stock units through Elanco's Directors' Deferral Plan.

Executive Vice President of Elanco Animal Health, Rajeev A. Modi, reports the acquisition of deferred stock units convertible to common stock or cash.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reports acquiring deferred stock units convertible to common stock or cash.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units representing the right to receive common stock or cash equivalent.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC Form 4 filing.

Jeffrey N. Simmons, CEO of Elanco Animal Health, reports acquisition of deferred stock units.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported changes in beneficial ownership related to deferred stock units.

Director Michael J. Harrington of Elanco Animal Health Inc. purchased 3,500 shares of common stock on August 22, 2024.

Elanco Animal Health's CEO, Jeffrey Simmons, recently purchased 100,000 shares of the company's common stock at an average price of $13.0061 per share.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reports the acquisition of deferred stock units convertible to common stock.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reports the acquisition of deferred stock units on July 26, 2024.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock or cash.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on July 12, 2024.

Elanco Animal Health's CEO, Jeffrey Simmons, reported the acquisition of deferred stock units on July 12, 2024.

Grace McArdle, EVP at Elanco Animal Health, disposed of 4,345 shares to cover tax liabilities upon vesting of restricted stock units.

James Meer, Chief Accounting Officer of Elanco Animal Health, reports the disposal of 1,160 shares to cover tax liabilities upon vesting of restricted stock units.

Elanco Animal Health's CEO, Jeffrey Simmons, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

Director Lawrence Kurzius elected to defer director fees into Elanco Animal Health Inc. stock units.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on June 28, 2024.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units on May 31, 2024.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock or cash.